Ketamine Assisted Therapy

Ketamine was approved by the FDA in 1970 and has been a popular anesthetic due its excellent safety profile. The administration of ketamine in lower, sub-anesthetic doses to treat pain, depression, addiction, or other psychiatric diagnoses is a newer, off-label use of ketamine that has become relatively wide-spread in recent years. Ketamine can be administered by intravenous (IV), intramuscular (IM), sublingual, oral, and intranasal routes. Our approach utilizes an oral lozenge route, rather than IV or IM since it tends to be gentler and allows the process to occur in a comfortable, therapeutic environment.

Sessions are typically 3 hours in length and involve preparation (30 min.), ketamine session (approximately 90 minutes), and integration time (1 hour). This results in a relaxation from ordinary concerns and a disconnection from the current view of “self.” These experiences tend to disrupt negative feelings and obsessional preoccupations. It is our experience that this relief and the exploration of other possible states of consciousness can be singularly impactful. The ketamine sessions are then coupled with integrative therapy sessions, to process and make sense of the experience, which in turn may lead to greater symptom reduction and duration of benefit.

We begin our Ketamine Assisted Therapy (KAT) process with a clinical intake interview to assess the client’s readiness and appropriateness for this work. Based on their specific interests, needs, and goals, we will work together to develop a plan of action. This plan typically involves several preparation sessions and medical screening, leading to 1 or more ketamine sessions. Following each ketamine session we will provide integration sessions to help explore any insights gained as well as therapeutic support to make meaningful changes in daily life.

If you are unable to use this link, please e-mail us at info@neuromeditationinstitute.com.

For more information, watch the video below